SpeedWeed

AUGUST 11, 2021

MAPS Makes History. If so, we will seek to return that generosity by developing a public-benefit cannabis pharmaceutical product that would be eligible for insurance coverage, just like any other pharmaceutical drug.”. PTSD affects a large number of military veterans.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

FEBRUARY 15, 2022

They offer a standardized process for making cannabis powder, highlight instruments, and demand high quality data. This small business has extraordinary ability, expertise, and intellectual property usually reserved for billion dollar pharmaceutical or public corporations. Grillo, Founder, Le Herbe.

Research and Development 52

Research and Development Trichome Digestion Edibles 52

SpeedWeed

JULY 8, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

Medicinal Genomics

SEPTEMBER 4, 2020

Did a stint in the pharmaceutical business. Later, a very productive stint in the pharmaceutical business working on some of the very largest drug franchises rounded out his education and created the impetus to start his own testing lab business in 2011. We have access to so much data and sharing it is powerful. Claim to Fame.

Hemp 52

Hemp Pharmaceutical Agriculture History 52

Cannabis Law Report

NOVEMBER 14, 2019

The changes will allow GPs to prescribe medical cannabis to patients but specialist approval will still be needed for children under 16 and patients with a history of drug abuse. The Department of Health reviewed three years of prescribing data in the lead-up to its decision.

Patients 45

Patients Access Medicine Pharmaceutical 45

SpeedWeed

JULY 8, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

SpeedWeed

JULY 7, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

SpeedWeed

JULY 7, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.

Research and Development 52

Research and Development Pharmaceutical Cannabinoids Supply Chain 52

SpeedWeed

JULY 6, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”.

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

Veriheal

AUGUST 31, 2020

Essay Summary: Although doctors’ offices are full of pamphlets and flyers about mainstream pharmaceuticals in both English and Spanish, there is a lack of information for Hispanic patients seeking relief with cannabis and CBD. . Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 8, 2021

All the data points associated to tagging and testing are tracked by uploading to a secure cloud database. The CertainT platform can be used across industries such as textiles, cannabis, military, leather, fertilizer, pharmaceuticals, personal care. About Flora Growth Corp. For more information, please visit [link].

Supply Chain 96

Supply Chain Therapy Pharmaceutical Food 96

Cannabis Law Report

JANUARY 6, 2022

An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. The history of ballot measures in Oregon developed from the state’s early populist leanings.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

DECEMBER 6, 2021

The Company recently presented initial data describing a methodology and findings for the successful determination of Egyptian cotton fiber, yarn and fabric origin using the combination of cotton genomics and isotopic analysis (IA) at an American Apparel and Footwear Association event.

Supply Chain 52

Supply Chain Therapy Research and Development Data 52

The Cannigma

AUGUST 5, 2022

When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” But for thousands of people, these little pills aren’t enough.

Treatment 140

Treatment Research and Development Therapy Digestion 140

Cannabis Law Report

JUNE 7, 2021

1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The study showed neutralizing antibody titers against B.1.1.7 Dr. James A.

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

Cannabis Law Report

AUGUST 16, 2021

It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child. “My Help better the AMMA!

Safety 116

Safety Patients Cannabis Law 116

Cannabis Law Report

SEPTEMBER 27, 2021

All the data points associated with tagging and testing are tracked by uploading to a secure cloud database. The CertainT platform can be used across industries, including textiles, cannabis, military, leather, fertilizer, pharmaceuticals, and personal care. About Applied DNA Sciences.

Supply Chain 52

Supply Chain Therapy Research and Development Pharmaceutical 52

Cannabis Law Report

JANUARY 4, 2022

Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. Assay (the “Linea 2.0 With the conditional approval, ADCL can immediately employ the Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

DECEMBER 15, 2021

The signing of the MoU follows the joint presentation of initial data by the companies at an American Apparel and Footwear Association event that describes a methodology and findings for the successful determination of Egyptian cotton fiber, yarn and fabric origin using cotton genomics with affirmation by IA.

Supply Chain 52

Supply Chain Therapy Research and Development Events 52

Cannabis Law Report

FEBRUARY 2, 2022

After the Company’s acquisition of a portfolio of CBD merchant accounts in the last quarter, OLB has started the current year with the highest revenue run rate in the history of the company. post-pandemic owing to increasing demand from the pharmaceutical sector and rising awareness among consumers regarding health.” ( See [link] ).

eCommerce 52

eCommerce CBD Environment Pharmaceutical 52

Cannabis Law Report

OCTOBER 3, 2019

” Dr. Titus’ presentation will highlight the history of hemp and how the widespread acceptance of the plant has positively shifted in the U.S. According to New Frontier Data , the global hemp market reached $3.74 and throughout the world in the past 10 years. billion by 2020. Medical Marijuana, Inc.

Events 40

Events Hemp Research and Development Supply Chain 40

Cannabis Law Report

DECEMBER 2, 2021

Training programs will educate students on the history of fungi and plant medicines, its use in indigenous and shamanic traditions, the pharmacology of psilocybin, the basic neuroscience relating to psilocybin, and psilocybin’s potential in treating depression, substance use, end-of-life issues, anxiety, trauma, and spirituality.

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

JANUARY 18, 2022

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Research and Development 52

Research and Development Therapy Supply Chain Collective 52

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. doctors, dentists, radiographers, nurses, pharmacists and psychologists) for patients who do not fit the Category A definition and where the UTG is not deemed to have an ‘established history of use’ Approval from the TGA is required before the UTG may be accessed.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

JULY 9, 2019

The active substance THC may be used in pharmaceuticals, whereas the use of the hemp blossom as a drug is not permitted. According to the ministry the published data on the application of CBD in a recent pubmed-research are not sufficient for the assessment of a therapeutic effect. CBD therefore is not a medicinal product by function.

Food 40

Food Seed-To-Sale Sativa Extraction 40

Cannabis Law Report

JANUARY 21, 2022

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Collective 52

Collective Therapy Research and Development Supply Chain 52

Cannabis Law Report

SEPTEMBER 2, 2021

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

Cannabis Law Report

OCTOBER 12, 2021

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Info

MARCH 2, 2019

It is only in recent human history, that this mighty herb fell victim to human greed and was bound into the chains of prohibition. Cannabis has been shown in several studies to successfully treat seizures , completely eradicating them in some cases.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

CannaTech

OCTOBER 14, 2018

California Hemp History. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. About Isodiol: Isodiol® is the global innovator and worldwide leader in the development of CBD-based pharmaceuticals and CBD consumer products. In the U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Cannabis Law Report

JUNE 2, 2021

Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Cannabis Law Report

NOVEMBER 5, 2021

Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. CLEARED4 captures, validates and matches user’s information to real-time health data including health surveys, temperature screening, integrated COVID-19 test results and vaccination status. Visit adnas.com for more information.

Compliance 52

Compliance Compliance Research and Development Therapy 52

Cannabis Law Report

AUGUST 3, 2021

Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

JANUARY 28, 2022

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.

Therapy 52

Therapy Research and Development Supply Chain Events 52

SpeedWeed

MARCH 7, 2021

Mark does have quite a bit to share with us, but as always, we’re going to check in with Ed to see what he’s uncovered this week from the data vault. This one was on the advisory sector, which focuses on consultants as well as essentially data analytics firms, so that was fun to dig back into that. View original article.

Extraction 52

Extraction Data Hemp Research and Development 52

Cannabis Law Report

JULY 24, 2022

analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 Data Bridge Market Research , (last viewed 13 July 2022). [2] billion by 2029. [1]

Research and Development 52

Research and Development Legalization Treatment Patients 52

SMPL

MAY 26, 2020

“There was a strong sense that this was really going to be something, if when people use these strains they have any kind of experience like the mice did in the laboratories,” said Martin Lee, a writer who at the time had been finishing a book about the social history of marijuana for Simon & Schuster.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40